Establishes the "Prescription Drug Savings and Transparency Act of 2026" to evaluate the benefits of consolidated prescription drug management within.
The "Prescription Drug Savings and Transparency Act of 2026" aims to assess whether Rhode Island would benefit from adopting a consolidated prescription drug management program within its Medicaid program. The act authorizes the office of the auditor general to conduct a comprehensive study, evaluating various prescription drug management structures used by other states.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.